Exuperio Díez-Tejedor Selected Research

Exuperio Díez-Tejedor Research Topics

Disease

52	Stroke (Strokes) 01/2021 - 01/2007
33	Ischemic Stroke 01/2022 - 01/2005
10	Infarction (Infarctions) 01/2022 - 09/2006
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 02/2012
4	Embolic Stroke 01/2020 - 09/2006
4	Hypertension (High Blood Pressure) 01/2020 - 03/2010
4	Ischemia 01/2020 - 08/2014
4	Brain Ischemia (Cerebral Ischemia) 08/2014 - 01/2009
3	Infections 05/2022 - 01/2013
3	Thrombosis (Thrombus) 01/2022 - 01/2009
3	Inflammation (Inflammations) 08/2021 - 01/2009
3	Hyperglycemia 11/2020 - 10/2010
3	Cerebral Infarction 11/2018 - 03/2010
2	COVID-19 05/2022 - 01/2021
2	Multiple Sclerosis 08/2021 - 04/2010
2	Aphasia (Dysphasia) 01/2021 - 11/2018
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020 - 01/2015
2	Cerebral Hemorrhage 01/2018 - 01/2012
2	Transient Ischemic Attack 04/2012 - 01/2009
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 08/2021
1	Atherosclerosis 07/2021
1	Pain (Aches) 02/2021
1	Cluster Headache (Cluster Headaches) 02/2021
1	Wernicke Aphasia (Receptive Aphasia) 01/2021
1	Critical Illness (Critically Ill) 11/2020
1	Broca Aphasia (Expressive Aphasia) 01/2019
1	POEMS Syndrome (Syndrome, POEMS) 11/2018
1	Paraproteinemias (Monoclonal Gammopathy) 11/2018
1	Multiple Myeloma 11/2018
1	Hemorrhage 09/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 09/2018
1	Neuroinflammatory Diseases 01/2018
1	Hypoxia (Hypoxemia) 01/2017
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 05/2016
1	Neoplasms (Cancer) 02/2015
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2015

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2014
6	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 02/2009
6	Cytidine Diphosphate Choline (Citicoline)IBA 08/2016 - 09/2006
5	AnticoagulantsIBA 01/2020 - 01/2012
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2012
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2013 - 01/2009
4	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2012 - 09/2008
3	Insulin (Novolin)FDA Link 11/2020 - 10/2010
3	salicylhydroxamic acid (SHAM)IBA 11/2020 - 01/2015
3	Glial Fibrillary Acidic ProteinIBA 01/2019 - 02/2015
3	SynaptophysinIBA 01/2019 - 02/2012
3	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 03/2010
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2016 - 11/2014
2	EnzymesIBA 07/2021 - 01/2015
2	Pharmaceutical PreparationsIBA 02/2021 - 08/2016
2	Niacinamide (Nicotinamide)FDA LinkGeneric 11/2020 - 01/2019
2	Streptozocin (Streptozotocin)FDA Link 11/2020 - 01/2019
2	Therapeutic UsesIBA 01/2020 - 01/2017
2	A-factor (Streptomyces)IBA 07/2016 - 08/2011
2	Endothelin-1 (Endothelin 1)IBA 06/2015 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2014 - 09/2006
2	Interleukin-6 (Interleukin 6)IBA 08/2014 - 09/2012
1	fibrin fragment D (D-dimer)IBA 05/2022
1	COVID-19 VaccinesIBA 01/2022
1	ImmunosorbentsIBA 07/2021
1	Proteins (Proteins, Gene)FDA Link 07/2021
1	MicroRNAs (MicroRNA)IBA 07/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2019
1	SolutionsIBA 01/2019
1	CollagenIBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2018
1	Lenalidomide (CC 5013)FDA Link 11/2018
1	Vitamin K FDA Link 09/2018
1	Blood Glucose (Blood Sugar)IBA 03/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	Collagenases (Collagenase)FDA Link 01/2018
1	Myelin ProteinsIBA 01/2018
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2018
1	Mitochondrial DNA (mtDNA)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Endothelins (Endothelin)IBA 01/2016
1	Type 1 Angiotensin ReceptorIBA 05/2015
1	olmesartanIBA 05/2015
1	Myelin Basic ProteinIBA 01/2015
1	Immunoglobulin G (IgG)IBA 01/2015
1	Immunoglobulin M (IgM)IBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA 01/2015

Therapy/Procedure

22	Therapeutics 01/2022 - 01/2005
5	Thrombectomy 01/2021 - 05/2016
5	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 01/2009
4	Intravenous Administration 01/2021 - 01/2013
1	Language Therapy (Language Training) 01/2021
1	Punctures 01/2021
1	Intraperitoneal Injections 11/2020
1	Decompressive Craniectomy 01/2020
1	Aftercare (After-Treatment) 09/2018
1	Bloodletting 03/2017
1	Microbubbles 01/2016
1	Patient Transfer (Patient Dumping) 08/2015